Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Using Drugs Appropriately

The Ministry of Health monitors the use of select drugs to ensure health outcomes occur as stated in the manufacturer's documentation. Where that does not occur, an intervention may occur and a financial adjustment may be made against the manufacturer.

We use de-identified prescription records from our database for internal and external drug studies, and use this research to make care safer.

We also restrict the coverage of Exception Drug Status drugs which are only intended for use under certain circumstances.

Programs and services
The following programs and services ensure safe drug use and help people receive the best results from prescription medications:

  • The Drug Evaluation Services and Roving Professor Program based at the University of Saskatchewan assists the drug review process, and provides expert opinions and drug information to promote the safest use of pharmaceuticals in the province. 
  • The Saskatchewan Drug Information Service provides drug information services for the public, pharmacists, physicians, and other health care professionals throughout Saskatchewan.  
  • The RxFiles Academic Detailing Program operated by the Saskatoon Regional Health Authority assists physicians in selecting the most appropriate and cost-effective drug therapy for their patients. 
  • The Prescription Review Program (formerly known as the Triplicate Prescription Program) is operated by the College of Physicians and Surgeons and is designed to reduce abuse and diversion. The prescription information required to operate this program is captured electronically through the Prescription Information Program (PIP). PIP is part of the provincial electronic health record. 
  • The Trial Prescription Program encourages pharmacists to dispense a seven or ten day supply for the initial prescription of certain drugs, monitor the effect on the patient, and if the outcomes are positive, dispense the full prescription as directed by the physician. This service helps ensure the best results for patients and reduces waste. There is no additional cost to the patient for this service.

How the program works

The pharmacy claims processing system checks on each prescription that is filled. An online computer network transmits prescription information from the pharmacy to the central computer where it is checked to determine if it can be approved for payment, including:

  • Is the drug a benefit?
  • Does the beneficiary have health coverage and the type?
  • Is the quantity dispensed within appropriate levels?
  • Is the number of prescriptions for the beneficiary within limits?
  • Is the prescription a duplicate or possible duplicate of another dispensed prescription?
  • Is the prescriber authorized?
  • Are the unit costs within limits?

After the check is completed, the prescription claim is adjudicated and cost information is transmitted back to the pharmacy, detailing the consumer share and Drug Plan share.

We need your feedback to improve Help us improve